e-learning
resources
Virtual 2020
Pre-Congress Content
Advance in treatments for sleep and breathing disorders and long-term adherence
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The frequency of medical co-morbidities and their impact on adherence to upper airway stimulation for obstructive sleep apnea.
P. Strollo (Pittsburgh, United States of America), R. Soose (Pittsburgh, United States of America), C. Heiser (Munich, Germany), A. Steffen (Lubeck, Germany), J. Maurer (Mannheim, Germany), O. Vanderveken (Edegem, Belgium)
Source:
Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Session:
Advance in treatments for sleep and breathing disorders and long-term adherence
Session type:
E-poster session
Number:
2492
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Strollo (Pittsburgh, United States of America), R. Soose (Pittsburgh, United States of America), C. Heiser (Munich, Germany), A. Steffen (Lubeck, Germany), J. Maurer (Mannheim, Germany), O. Vanderveken (Edegem, Belgium). The frequency of medical co-morbidities and their impact on adherence to upper airway stimulation for obstructive sleep apnea.. 2492
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Long-term response of upper airway stimulation in obstructive sleep apnea
Source: Annual Congress 2012 - Paediatrics and sleep apnoea/adults and upper airway stimulation
Year: 2012
Why should we care about upper airway inflammation in obstructive sleep apnoea?
Source: Eur Respir J 2016; 48: 982-983
Year: 2016
Impact of CPAP on asthmatic patients with obstructive sleep apnoea
Source: Eur Respir J 2007; 29: 307-311
Year: 2007
Effects of vertical opening on upper airway dimensions during drug-induced sleep endoscopy in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Year: 2011
Effect of upper-airway stimulation for obstructive sleep apnoea on airway dimensions
Source: Eur Respir J 2015; 45: 129-138
Year: 2015
Predictors of continuous positive airway pressure adherence in obstructive sleep apnea syndrome
Source: International Congress 2017 – Inhalers and their use
Year: 2017
Compliance in sleep apnoea therapy: influence of home care support and pressure mode
Source: Eur Respir J 2009; 33: 804-811
Year: 2009
Analysis of arousability of upper airway stimulation in obstructive sleep apnea
Source: Annual Congress 2012 - Paediatrics and sleep apnoea/adults and upper airway stimulation
Year: 2012
The effect of concomitant COPD on obstructive sleep apnea syndrome severity and sleep structure
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
The impact of smoking status on obstructive sleep apnea (OSA) severity.
Source: International Congress 2018 – Sleep and breathing control: phenotypes
Year: 2018
Telecoaching to improve physical activity in patients with obstructive sleep apnea treated with CPAP
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020
A new method to determine the site of upper airway obstruction using sleep induced endoscopy in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea : physiology, diagnostic tools and technology
Year: 2011
Effects of upper airway obstruction sites on polysomnographic parameters and clinical manifestations in patients with obstructive sleep apnea
Source: Eur Respir J 2006; 28: Suppl. 50, 643s
Year: 2006
Pathophysiology of the upper airway in obstructive sleep apnoea
Source: Annual Congress 2006 - PG9 - Obstructive sleep apnoea: current pathophysiological, clinical and therapeutic concepts
Year: 2006
Influence of smoking on symptoms, comorbidities and severity in a population with obstructive sleep apnea (OSA) versus control
Source: Annual Congress 2011 - Epidemiology of smoking and smoking cessation interventions
Year: 2011
The role of ethnicity in the upper airway in a Belgian paediatric population with obstructive sleep apnoea
Source: Eur Respir J, 50 (4) 1701278; 10.1183/13993003.01278-2017
Year: 2017
Polygraphic patterns predictive of success of upper airway surgery in obstructive sleep apnea patients
Source: International Congress 2018 – Treatments that can serve as an alternative to positive airway pressure (PAP)
Year: 2018
Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke
Source: Eur Respir J 2001; 18: 623-629
Year: 2001
Influence of electrostimulation of pharyngeal and laryngeal muscles in complex with traditional treatment of COPD on functional signs of obstructive sleep apnea syndrome in patients with combined pathology – obstructive sleep apnea syndrome + COPD
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007
Are symptoms of obstructive sleep apnoea related to good continuous positive airway pressure compliance?
Source: ERJ Open Res, 6 (3) 00169-2019; 10.1183/23120541.00169-2019
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept